Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States

Filetype[PDF-320.14 KB]


English
Details Supporting Files You May Also Like

Details:

  • Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.)
  • Content Notes:
    Background -- Authorized age groups -- Vaccine administration -- Interchangeability of COVID-19 vaccine products -- People vaccinated outside the United States -- Coadministration with other vaccines -- Booster doses -- COVID-19 vaccination and SARS-CoV-2 infection -- Antiviral therapy and COVID-19 vaccination -- Vaccinating people with a known COVID-19 exposure or during COVID-19 outbreaks -- Considerations for vaccination of people with certain underlying medical conditions -- Considerations for use of the Janssen COVID-19 vaccine in certain populations -- Vaccination of pregnant or lactating people -- Vaccination of children and adolescents -- Patient counseling -- Contraindications and precautions -- Reporting of vaccine adverse events -- Laboratory testing -- Appendix A. Vaccine administration errors and deviations -- Appendix B: Triage of people presenting for COVID-19 vaccination -- Appendix C: Ingredients included in COVID-19 vaccines -- Appendix D: Potential characteristics of allergic reactions, vasovagal reactions, and vaccine side effects following COVID-19 vaccination -- References -- Previous Updates .
  • Subjects:
  • Document Type:
    Webpage
  • Place as Subject:
    United States
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

You May Also Like

Checkout today's featured content at stacks.cdc.gov